AEON Biopharma elects Fischer and Carter as Class II directors; ratifies KPMG

AEON Biopharma, Inc.

Jost Fischer and Eric Carter elected as Class II directors for three-year terms ending 2028.
Fischer received 661,774 votes for and 138,295 withheld; Carter 674,894 for and 125,175 withheld.
KPMG ratified as independent auditor for FY 2025 with 4,956,438 for, 170,672 against, 30,177 abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.